SC
Subash Chander Sehgal
About Subash Chander Sehgal
Data last updated:
Subash Chander Sehgal is a Managing Director at Ozone Pharmaceuticals Limited (since 1996), Managing Director at North East Mega Food Park Limited (since 2009) and Director at Assam Agrotech Private Limited (since 2010), and holds 5 more current directorships. The companies operate in Pharma, Infrastructure and Utilities and Agriculture. The 4 current companies with reported revenue have a combined latest revenue of ₹341 Cr; the largest is Ozone Pharmaceuticals Limited at ₹337 Cr (FY 2025). Earlier, Subash Chander Sehgal was a Nominee Director at J4serv Private Limited (2017–2021) and Director at Avizen Biopharma Private Limited (2016) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 21 Jun 1996 | 1991 | ₹337 Cr (FY 2025) | Active | |
| Managing Director | 25 Feb 2009 | 2009 | ₹1.67 Cr (FY 2025) | Active | |
| Director | 10 Sep 2010 | 2010 | ₹1.48 Cr (FY 2025) | Active | |
| Director | 22 Apr 2008 | 2008 | ₹9,020 (FY 2025) | Active | |
| Director | 16 Apr 2025 | 2025 | Active | ||
| Director | 23 Feb 2024 | 2024 | Active | ||
| Director | 01 Jun 2023 | 2023 | Active | ||
| Designated Partner | 07 Mar 2016 | 2016 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Nominee Director | 12 Apr 2017 | 2015 | ₹3,335 (FY 2024) | Strike Off | |
| Director | 09 Aug 2016 | 2016 | ₹20.61 Cr (FY 2025) | Active | |
| Director | 10 Jun 2003 | 2003 | Amalgamated | ||
| Director | 28 Jun 2006 | 2006 | Strike Off | ||
| Director | 11 Apr 2013 | 2013 | Strike Off | ||
| Director | 30 Apr 2012 | 2012 | ₹28.3 Lakh (FY 2022) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Subash Chander Sehgal
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subash Chander Sehgal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subash Chander Sehgal
Subash Chander Sehgal currently holds 8 directorships: Ozone Pharmaceuticals Limited (Managing Director, since 21 Jun 1996, revenue ₹337 Cr (FY 2025)); North East Mega Food Park Limited (Managing Director, since 25 Feb 2009, revenue ₹1.67 Cr (FY 2025)); Assam Agrotech Private Limited (Director, since 10 Sep 2010, revenue ₹1.48 Cr (FY 2025)); 4Thd Pharma Private Limited (Director, since 22 Apr 2008, revenue ₹9,020 (FY 2025)); Ozone Health And Lifesciences Private Limited (Director, since 16 Apr 2025); and 3 more.
Subash Chander Sehgal was first appointed on 21 Jun 1996 as Managing Director at Ozone Pharmaceuticals Limited. The most recent appointment on record is 16 Apr 2025 at Ozone Health And Lifesciences Private Limited.
The 4 current companies of Subash Chander Sehgal that report revenue have a combined latest revenue of ₹341 Cr: Ozone Pharmaceuticals Limited ₹337 Cr (FY 2025); North East Mega Food Park Limited ₹1.67 Cr (FY 2025); Assam Agrotech Private Limited ₹1.48 Cr (FY 2025); 4Thd Pharma Private Limited ₹9,020 (FY 2025).
Subash Chander Sehgal held 6 earlier board appointments: J4serv Private Limited (Nominee Director, 12 Apr 2017 to 01 Apr 2021); Avizen Biopharma Private Limited (Director, 09 Aug 2016 to 19 Oct 2016); Fourth Dimension Media Private Limited (Director, from 10 Jun 2003); Ozone Agro & Foods Private Limited (Director, from 28 Jun 2006); Life N Style Realtech Private Limited (Director, from 11 Apr 2013); and 1 more.
The current boards of Subash Chander Sehgal's companies include Akarsh Kashyap (Ozone Pharmaceuticals Limited), Anju Bala (Ozone Pharmaceuticals Limited), Anupam Verma (Ozone Pharmaceuticals Limited), Dipak Kumar Singh (Ozone Pharmaceuticals Limited), Geeta Sehgal (Ozone Pharmaceuticals Limited), Neelam Oberoi (Ozone Pharmaceuticals Limited), among others.